The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila Euro. Regulatory News (AERI)

Share Price Information for Aquila Euro. (AERI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.71
Bid: 0.71
Ask: 0.738
Change: 0.01 (1.40%)
Spread: 0.028 (3.944%)
Open: 0.71
High: 0.726
Low: 0.71
Prev. Close: 0.714
AERI Live PriceLast checked at -
Aquila European Renewables Income is an Investment Trust

To generate stable returns, principally in the form of income distributions, by investing in a diversified portfolio of Renewable Energy Infrastructure Investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

27 Aug 2021 16:45

RNS Number : 0754K
Aquila European Renewables Income
27 August 2021
 

 Aquila European Renewables Income Fund PLC

Publication of Supplementary Prospectus

27 August 2021

 

Aquila European Renewables Income Fund PLC (the "Company"), announces that it has today published a supplementary prospectus approved by the FCA (the "Supplementary Prospectus"). The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 17 September 2020 (the "Prospectus").

The Supplementary Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at www.aquila-european-renewables-income-fund.com.

Sponsor, Broker and Joint Bookrunner in the UKNumis Securities (UK Investors) | +44 (02)0 7260 1000Tod DavisDavid BendaVicki Paine

Joint BookrunnerKempen & Co (EU Investors in the Target Jurisdictions) | +31 (0) 20 348 8000

Thomas ten Hoedt

Maarten de Zeeuw

 

 

Administrator and Company Secretary

PraxisIFM Fund Services (UK) Limited | +44 (0) 20 7332 2986

Brian Smith

 

 

Important Information

 

The distribution of this Announcement and/or the issue of New Ordinary Shares ("New Shares") in certain jurisdictions under the Placing Programme may be restricted by law and/or regulation. No action has been taken by the Company, Numis Securities Limited ("Numis") or Van Lanschot Kempen N.V. ("Kempen & Co") or any of their respective affiliates that would permit an offer of New Shares or possession or distribution of this Announcement or any other publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons receiving this Announcement are required to inform themselves about and to observe any such restrictions.

 

Numis, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no-one else in connection with the Issue or the Placing Programme or in relation to the matters referred to in the Prospectus and will not regard any other person (whether or not a recipient of this document) as its client in relation to the Issue or the Placing Programme and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Issue or the Placing Programme, the contents of this document or any transaction or arrangement referred to in the Prospectus.

Kempen & Co, which is authorised and regulated in the Netherlands by the Dutch Authority for Financial Markets and the Dutch Central Bank, is acting exclusively for the Company and no-one else in connection with the Placing and the Placing Programme or in relation to the matters referred to in the Prospectus, will not regard any other person (whether or not a recipient of this document) as its client in relation to the Placing or the Placing Programme and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or the Placing Programme, the contents of this document or any transaction or arrangement referred to in the Prospectus. Kempen & Co is not acting for or providing services to the Company or any other person in respect of the Offer for Subscription and will not be responsible to any person in respect of any claim or any other matter arising from the Offer for Subscription.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPPPUWCRUPGGAM
Date   Source Headline
5th Feb 20215:13 pmRNSIssue of Equity to Investment Adviser
5th Feb 20217:00 amRNSDividend Declaration
5th Feb 20217:00 amRNSNet Asset Value and Factsheet - 31 December 2020
30th Dec 20208:25 amRNSAquisition
23rd Dec 20204:04 pmRNSCompletion of Acquisition
4th Dec 20207:00 amRNSAcquisition
1st Dec 20207:00 amRNSTotal Voting Rights
5th Nov 20205:08 pmRNSIssue of Equity to Investment Adviser
5th Nov 20207:00 amRNSNet Asset Value and Factsheet - 30 September 2020
2nd Nov 20207:00 amRNSTotal Voting Rights
30th Oct 20207:00 amRNSInvestment Update
19th Oct 20204:48 pmRNSHolding(s) in Company
15th Oct 20203:26 pmRNSHolding(s) in Company
14th Oct 20205:20 pmRNSHolding(s) in Company
14th Oct 20205:09 pmRNSHolding(s) in Company
13th Oct 20205:21 pmRNSHolding(s) in Company
13th Oct 202012:50 pmRNSHolding(s) in Company
9th Oct 20207:00 amRNSIssue of Equity
6th Oct 202011:40 amRNSResult of General Meeting
30th Sep 20202:58 pmRNSDividend Declaration
17th Sep 202010:01 amRNSPublication of a Prospectus and Circular
15th Sep 20207:00 amRNSHalf-year Report
11th Sep 20208:51 amRNSAcquisition
2nd Sep 20203:04 pmRNSTotal Voting Rights
5th Aug 20203:50 pmRNSIssue of Equity to Investment Adviser
5th Aug 20207:02 amRNSIssue of Equity to Investment Adviser
5th Aug 20207:01 amRNSDividend Declaration
5th Aug 20207:00 amRNSNet Asset Value and Factsheet - 30 June 2020
31st Jul 20207:00 amRNSChange of Registered Office
8th Jun 20204:48 pmRNSResult of AGM
5th Jun 20204:19 pmRNSInvestment Update
13th May 20207:00 amRNSIssue of Equity to Investment Adviser
12th May 20207:02 amRNSNet Asset Value and Factsheet - 31 March 2020
12th May 20207:00 amRNSDividend Declaration
28th Apr 20207:00 amRNSFinal Results
2nd Apr 20202:59 pmRNSHolding(s) in Company
1st Apr 20206:18 pmRNSTotal Voting Rights
23rd Mar 20207:00 amRNSInvestment Update
11th Mar 20206:07 pmRNSHolding(s) in Company
11th Mar 20205:54 pmRNSHolding(s) in Company
9th Mar 20201:35 pmRNSHolding(s) in Company
6th Mar 20202:03 pmRNSIssue of Equity
5th Mar 20207:00 amRNSProposed Issue of Equity
11th Feb 202012:37 pmRNSIssue of Equity to Investment Adviser
11th Feb 202012:31 pmRNSNet Asset Value & Factsheet - 31 December 2019
11th Feb 202012:24 pmRNSDividend Declaration
22nd Jan 20204:46 pmRNSHolding(s) in Company
22nd Jan 20209:43 amRNSHolding(s) in Company
20th Jan 20203:08 pmRNSHolding(s) in Company
20th Dec 20194:50 pmRNSInvestment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.